Monogram Provides Update On Trofile(TM) Co-Receptor Tropism Assay

Sat, 02 Dec 2006 02:00 PM EST

... Monogram Biosciences, Inc. (Nasdaq: MGRM) announced today that its collaborator Pfizer, Inc. (NYSE: PFE) has separately announced plans to establish a multi-national Expanded Access Program (EAP) that will make its investigational CCR5 antagonist maraviroc available to HIV/AIDS patients who have limited treatment options due to resistance or intolerance. [click link for full article] ...